IE
IE · IE · IE-PA-EU/1/17/1231/001-002
Ocrevus 300 mg concentrate for solution for infusion
ATC L04AA36
Last synced from HPRA (Ireland) on
Identification
ManufacturerRoche Registration GmbH
CountryIE (IE)
ATC codeL04AA36
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/15/2026
Packs · 1
- ie_pa_numberEU/1/17/1231/001-002
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L04AA",
"L04AA36"
],
"strength": null,
"pa_number": "EU/1/17/1231/001-002",
"substances": [
"Ocrelizumab"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Access this data programmatically
Query Ocrevus 300 mg concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.